Dewpoint Therapeutics
Miook Cho has a Ph.D. in Human Genetics of Aging from Albert Einstein College of Medicine. They have experience working as a Postdoctoral Fellow at Harvard Stem Cell and Regenerative Biology, and Albert Einstein College of Medicine. Miook also has worked at Merck, Cygnal Therapeutics, and currently at Dewpoint Therapeutics in roles related to In Vitro Pharmacology.
Dewpoint Therapeutics
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.